<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T00:39:25Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/14076" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/14076</identifier><datestamp>2026-10-18T21:14:21Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Oleuropein and rutin protect against 6-OHDA-induced neurotoxicity in PC12 cells through modulation of mitochondrial function and unfolded protein response</dc:title><dc:creator>Elmazoglu, Zubeyir</dc:creator><dc:creator>Ergin, Volkan</dc:creator><dc:creator>Sahin, Ergin</dc:creator><dc:creator>Kayhan, Handan</dc:creator><dc:creator>Karasu, Cimen</dc:creator><dc:subject>endoplasmic reticulum</dc:subject><dc:subject>mitochondria</dc:subject><dc:subject>neurotoxicity</dc:subject><dc:subject>oleuropein</dc:subject><dc:subject>rutin</dc:subject><dc:subject>activating transcription factor 4</dc:subject><dc:subject>oxidopamine</dc:subject><dc:subject>protein disulfide isomerase</dc:subject><dc:subject>protein IRE1</dc:subject><dc:subject>rutoside</dc:subject><dc:subject>X box binding protein 1</dc:subject><dc:subject>animal cell</dc:subject><dc:subject>animal experiment</dc:subject><dc:subject>apoptosis</dc:subject><dc:subject>Article</dc:subject><dc:subject>cell differentiation</dc:subject><dc:subject>cell growth</dc:subject><dc:subject>cell proliferation</dc:subject><dc:subject>cell survival</dc:subject><dc:subject>cell viability</dc:subject><dc:subject>controlled study</dc:subject><dc:subject>endoplasmic reticulum stress</dc:subject><dc:subject>mitochondrial membrane potential</dc:subject><dc:subject>mitochondrion</dc:subject><dc:subject>neuromodulation</dc:subject><dc:subject>neuroprotection</dc:subject><dc:subject>nonhuman</dc:subject><dc:subject>oxidative stress</dc:subject><dc:subject>PC12 cell line</dc:subject><dc:subject>pheochromocytoma</dc:subject><dc:description>Parkinson's disease (PD) is a highly prevalent neurodegenerative disorder, often associated with oxidative stress-induced transcriptional changes in dopaminergic neurons. Phenolic antioxidants, oleuropein (OLE) and rutin (RUT) have attracted a great interest due to their potential to counteract oxidative protein aggregation and toxicity. This study aimed at examining the effects of OLE and RUT against 6-OHDA-induced stress response in rat pheochromocytoma cells. When differentiated PC12 cells were exposed to oxidative stress composer 6-OHDA (100 μM, 8 h), a decreased mitochondrial membrane potential (ΔΨm) was observed along with a significant loss of cell viability and apoptotic nuclear changes. Exposure to 6-OHDA resulted in unfolded protein response (UPR) in differentiated PC12 cells as evidenced by an increased level of endoplasmic reticulum (ER)-localized transmembrane signal transducer IRE1α, adaptive response proteins ATF-4 and proapoptotic transcription factor CHOP. OLE or RUT pretreatment (24 h) at low doses (1-50 μM) protected the differentiated PC12 cells from 6-OHDA-induced cytotoxicity as assessed by increased viability, improved ΔΨm and inhibited apoptosis, whereas relatively high doses of OLE or RUT (&gt;50 μM) inhibited cell growth and proliferation, indicating a typical hormetic effect. In hormetic doses, OLE and RUT up-regulated 6-OHDA-induced increase in IRE1α, ATF-4 and inhibited CHOP, PERK, BIP and PDI. 6-OHDA-activated XBP1 splicing was also inhibited by OLE or RUT. The presented results suggest that neuroprotection against 6-OHDA-induced oxidative toxicity may be attributable to neurohormetic effects of OLE or RUT at low doses through regulating mitochondrial functions, controlling persistent protein misfolding, activating and/or amplificating the adaptive response-related signaling pathways, leading to UPR prosurvival output. © 2018 Interdisciplinary Toxicology.</dc:description><dc:publisher>Slovak Toxicology Society</dc:publisher><dc:date>2017</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/14076</dc:identifier><dc:identifier>https://doi.org/10.1515/intox-2017-0019</dc:identifier><dc:identifier>1337-6853</dc:identifier><dc:language>en</dc:language><dc:relation>Interdisciplinary Toxicology</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/14076</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>